Reading Your Own Bloodwork: The Markers That Actually Change Decisions

Most people who run regular bloodwork make the same two mistakes: they look at whether each number falls inside the reference range, and they treat each panel as a snapshot rather than a data point in a series. Both habits waste most of the information the test contains.

Reference ranges are not health targets. They are statistical descriptions of where the middle ninety-five percent of a reference population fell — a population that, for most labs, includes a great many people with undiagnosed metabolic dysfunction. Being inside the range means you resemble the average person tested, which in several cases is a low bar.

This guide covers the markers that most often change what a reasonable person would actually do, how to interpret them, and where the common misreadings occur.

Cardiovascular Risk: The Markers That Matter Most

ApoB

If you track one cardiovascular marker, this is the strongest candidate. Apolipoprotein B is a structural protein present at exactly one copy per atherogenic lipoprotein particle — LDL, VLDL, IDL, and lipoprotein(a). Measuring ApoB therefore counts the number of particles capable of depositing cholesterol in an arterial wall.

This matters because atherosclerosis is driven by particle number more than by the cholesterol those particles carry. Two people can have identical LDL cholesterol with very different particle counts: one with fewer, larger, cholesterol-rich particles, another with many small, cholesterol-poor ones. The second person is at higher risk despite an identical LDL-C reading. This discordance is common in insulin-resistant and metabolic syndrome phenotypes — precisely the people who most need accurate assessment.

Where standard lipid panels report LDL-C, ApoB is the better discriminator and is increasingly recognised in guidelines. If your panel does not include it, it is usually inexpensive to add.

Lipoprotein(a)

Lp(a) is a genetically determined, largely diet- and exercise-insensitive lipoprotein that independently raises cardiovascular risk, and elevated levels affect roughly one in five people. It should be measured at least once in a lifetime. Because it is genetic and stable, repeated testing adds little — but knowing your number substantially changes how aggressively other modifiable risk factors should be managed. A great many people with elevated Lp(a) have never been tested and have no idea.

Triglyceride to HDL ratio

Calculated from a standard panel at no additional cost, this ratio is a useful proxy for insulin resistance and for the small-dense LDL phenotype. It is not diagnostic, but a rising ratio over time is an early signal that metabolic health is drifting, often before fasting glucose moves.

Metabolic Health

Fasting insulin and HOMA-IR

Fasting glucose is a late marker. The pancreas compensates for insulin resistance by secreting more insulin, holding glucose in the normal range for years while the underlying dysfunction progresses. By the time fasting glucose rises, considerable beta-cell capacity has been lost.

Fasting insulin catches this earlier. Combined with fasting glucose it yields HOMA-IR, a simple index of insulin resistance. Many standard panels omit fasting insulin entirely, which is a significant blind spot for anyone interested in metabolic health rather than diabetes diagnosis.

HbA1c and its limitations

HbA1c reflects average glycemia over roughly three months by measuring glycated haemoglobin. It is useful but has an important confounder: it depends on red blood cell lifespan. Conditions that shorten RBC survival produce falsely low readings; conditions that lengthen it produce falsely high ones. Athletes with high red cell turnover, people with anaemia, and people with haemoglobin variants can all get misleading results. If HbA1c conflicts with fasting glucose or symptoms, fructosamine or continuous glucose monitoring can clarify.

Inflammation

hs-CRP

High-sensitivity C-reactive protein measures low-grade systemic inflammation and independently predicts cardiovascular events. The key practical point is interpretive: hs-CRP rises sharply with any acute infection, injury, or even a hard training session in the preceding days. A single elevated reading in isolation usually means something recent happened, not that you have chronic inflammation. Repeat it a few weeks later, away from illness and hard training, before drawing conclusions.

Ferritin

Ferritin is both an iron storage marker and an acute-phase reactant, which makes it ambiguous on its own. High ferritin can mean iron overload or it can mean inflammation. Pairing it with transferrin saturation and hs-CRP resolves most of that ambiguity. Low ferritin with normal haemoglobin indicates depleted iron stores before anaemia develops — a common and easily missed cause of fatigue and poor training tolerance, particularly in menstruating women and endurance athletes.

Liver

ALT and AST are the standard enzymes, and their interpretation is more nuanced than most people assume. Strenuous resistance training raises AST substantially and ALT modestly, because both enzymes are present in skeletal muscle as well as liver. An athlete who trains hard two days before a blood draw can produce a pattern that looks like liver injury and is not.

The way to distinguish muscle from liver origin is to add GGT, which is liver-specific and unaffected by muscle damage, and creatine kinase, which is a direct index of muscle damage. Elevated AST and ALT with a normal GGT and a high CK points to muscle. Elevated GGT alongside them points to the liver.

GGT independently is worth tracking. It rises with alcohol intake, hepatic fat accumulation and oxidative stress, and it is one of the more sensitive early indicators of hepatic strain.

For anyone taking oral compounds metabolised hepatically — prescription or otherwise — this panel is the relevant monitoring set, and a baseline before starting is what makes subsequent values interpretable.

Haematology

Haemoglobin and haematocrit matter for anyone whose interventions might raise red cell mass. Rising haematocrit increases blood viscosity, and above roughly the mid-fifties percent range it becomes a genuine thrombotic concern warranting medical attention rather than self-management. Androgens, altitude, sleep apnoea, dehydration and smoking all push it up. A haematocrit rising over successive panels is a trend that should prompt a conversation with a physician, not a wait-and-see.

A full blood count also catches white cell abnormalities and platelet changes that no other panel will show.

Kidney

Creatinine and eGFR are the standard measures, with a well-known confounder: creatine supplementation raises serum creatinine without any change in kidney function, because creatinine is creatine’s breakdown product. This produces an artefactually low eGFR. Cystatin C is an alternative filtration marker unaffected by creatine intake or muscle mass, and it is the appropriate test when creatinine-based estimates are unreliable — which includes most people with substantial muscle mass, supplementing or not.

Urine albumin-to-creatinine ratio detects early kidney damage before eGFR moves and is worth including periodically, particularly with hypertension or metabolic dysfunction.

Hormones and Thyroid

For thyroid, TSH alone is insufficient. TSH is a pituitary signal, not a thyroid hormone measurement, and it can be normal in the presence of conversion problems. A useful panel includes TSH, free T4, free T3, and thyroid antibodies at least once — autoimmune thyroiditis is the most common cause of hypothyroidism and antibodies often precede overt dysfunction by years.

For sex hormones, total testosterone without SHBG and albumin is incomplete, because SHBG determines how much of that total is bioavailable. Two men with identical total testosterone and different SHBG have meaningfully different free testosterone. Oestradiol should be measured with a sensitive assay in men, as standard immunoassays perform poorly at male concentrations. Timing matters: testosterone follows a diurnal rhythm and should be drawn in the morning, consistently, for comparability. Our hormones guide covers this in more depth.

How to Actually Use the Data

Three principles do most of the work.

Establish a baseline while healthy. The value of a panel taken before you start anything is that it turns every later panel into a comparison rather than a guess. Without a baseline, an unusual value leaves you unable to distinguish a change from your normal.

Standardise the conditions. Same lab where possible, since reference ranges and assay methods differ. Fasted, morning, adequately hydrated. At least forty-eight to seventy-two hours away from hard training, which otherwise distorts liver enzymes, CK and hs-CRP. Consistency in how you draw is what makes trends real rather than noise.

Read trends, not points. A single value inside the range tells you little. A marker moving steadily in one direction across three panels tells you a great deal, even if every individual value is technically normal. Most of the useful signal in serial bloodwork is in the slope.

And when something is genuinely out of range or trending badly, the correct next step is a physician who can order confirmatory testing and put the result in the context of your history. Interpreting your own bloodwork is a way to be an informed participant in your healthcare, not a replacement for it.

A Reasonable Core Panel

For most people wanting a broad picture, a comprehensive metabolic panel, full blood count, lipid panel with ApoB, fasting insulin, HbA1c, hs-CRP, GGT, ferritin with transferrin saturation, a full thyroid panel, vitamin D, and a sex hormone panel with SHBG covers the majority of actionable findings. Lp(a) once. Cystatin C where creatinine is likely to mislead.

Frequency depends on what you are doing. Annually is reasonable for a stable, healthy adult. Anyone taking compounds with known effects on lipids, liver, haematocrit or hormones has reason to test more often, with a baseline first. Related material is in our bloodwork section and beginners guide.

This article is educational and is not medical advice. Laboratory results should be interpreted by a qualified healthcare provider in the context of your individual history and clinical picture.